A B S T R A C T It has been shown that active immunization of rats with the capsular polysaccharide of Bacteroides fragilis protects these animals against abscess development following intraperitoneal challenge with this species. Passive transfer of hyperimmune globulin from immunized animals to nonimmune recipients provided protection against B. fragilis bacteremia in challenged animals, but did not confer protection against abscess development. On the other hand, adoptive transfer of spleen cells from immunized animals to nonimmunized recipients resulted in protection against abscesses following challenge with B. fragilis. These data suggested that a T cell-dependent immune response was involved in protection against abscess development after immunization with B. fragilis capsular antigen.
INTRODUCTION
Among the obligate anaerobes, Bacteroides fragilis is the species most commonly isolated from a variety of clinical sources, including blood cultures (1, 2) . B. fragilis is also an important component for intraabdominal abscess formation in an experimental animal model (3) (4) (5) . It has been shown that B. fragilis strains contain an antigenically common capsular antigen not found on other phenotypically similar species of Bacteroides (B. distasonis, B. vulgatus, B. thetaiotaomicron, and B. ovatus) (6, 7) . The relationship of this capsular material to virulence was clarified by the observations that of the various Bacteroides species examined only B. fragilis, when implanted into the peritoneal cavity of rats with BaSO4 and sterile cecal contents, was capable of causing abscesses in the absence of other bacteria. Implantation of the capsular polysaccharide (CP)l of B. fragilis without viable bacteria also resulted in abscess formation in this model (4) . Subsequent experiments revealed that animals immunized with B. fragilis capsular antigen before intraperitoneal challenge developed significant rises in serum antibody concentration to the capsular antigen. These actively immunized animals were protected from development of abscesses when challenged with B. fragilis but were not protected against abscess development when challenged with a bacteriologically complex fecal inoculum. However, B. fragilis was not part of the microflora isolated from abscesses in immunized recipients who had been challenged with the fecal material, despite the presence of B. fragilis in the fecal inoculum. In addition, the early bacteremia with B. fragilis noted in nonimmunized animals did not occur in immunized animals (8) .
The present report analyzes the immunological basis for the protection conferred in the rat model by immunization with the B. fragilis capsule. Specifically we have found that abscess development can only be prevented in rats with intact T lymphocyte function and that protection against abscesses can be adoptively transferred with immune T cell-enriched populations, but not with immune serum, nor B cell-and macrophage-enriched populations. Immune serum did protect against bacteremia, indicating that protection against all the manifestations of B. fragilis infection, which is achieved after active immunization with capsular material, involves both humoral and cell-mediated immunity.
METHODS
Animals. Two inbred strains of rats were used during these studies. Wistar/Lewis rats were obtained from Charles River Breeding Laboratories (Wilmington, Mass.). Congenitally athymic OLA/Rnu rats homozygous for the athymic trait and their phenotypically normal littermates, heterozygous for the athymic trait were also used (Olac, Ltd., England). Male animals weighing 120 g were used for immunization protocols. At (Table I) . Animals were bled before immunization and subsequently were given 3 i.m. injections a week for 3 wk and a booster injection in the 4th wk. 5 wk after immunization was initiated, animals were either implanted with one of the bacterial inocula, exsanguinated for hyperimmune sera, or splenectomized. Postimmunization sera were obtained at the time of implantation. Groups receiving spleen cells were lightly anesthetized with ether 24 h before challenge and given 1.0 ml of a spleen cell preparation by the intracardiac route. Animals receiving hyperimmune globulin were given 0.5 ml of the globulin preparation intracardiac, at the time of implantation. All animals weighed between 180 and 200 g at the time of surgical implantation of the bacterial challenge. 7 d after challenge, all animals were killed and examined for the presence or absence of intraabdominal abscesses.
Immunization
The preparation of the antigens used for these studies and the immunization regimen have been described previously (8) . Briefly, animals were given i.m. injections of 10 ,ug of B. fragilis CP in 0.1 ml phosphate-buffered saline.
Immune globulin. Gamma globulin was prepared from pooled sera obtained from rats immunized with the B. fragilis capsule (9, 10) .
Serologic methods. Preimmunization sera and sera obtained at the time of bacterial challenge were tested. Antibody to the B. fragilis capsular antigen was quantitated by the radioactive antigen binding assay described previously (9) .
Preparation of spleen cells. Spleens were removed from immunized animals 5 wk after beginning immunization and placed into 20 ml of sterile Hanks' balanced salt solution at room temperature. The spleens were minced with sterile scissors and cells released by gentle disruption of the tissues on a stainless steel wire gauze. The cell preparation was filtered through sterile glass wool to remove cell clumps and then assayed for total cell density and viable cell density using manual counting methods and trypan blue exclusion. The viable cell density was routinely 85-90% of the total cell density. Following viability determinations, cell preparations were diluted appropriately with sterile Hanks' balanced salt solution. The final preparations were immediately injected into nonimmunized rats by the intracardiac route. The mortality rate for this procedure was <5% with all deaths occurring within 5 min of injection.
Nylon wool column methods. Separation of T and B cells from the rat spleen was performed using nylon wool columns. It is known that B cells and macrophages generally adhere to nylon wool, while T and null cells pass through. The methods used were those published by Julius et al. (11) . 35-cm3 syringe columns were set up with 3-way stopcocks and 18-gauge needles. 50 cm3 of balanced salt solution with 5% fetal calf serum, which was used as the media throughout, was run through the column. Spleens were removed from immunized rats and cells released by disruption with a stainless steel wire mesh gauze. The cells were passed through a dacron gauze filter to remove debris and counted using a Coulter Fn counter (Coulter Electronics Inc., Hialeah, Fla.). Preparation of bacterial challenge. Quantitative determinations of viable cell density were made by means of direct plate counts of each strain following freezing of the original culture preparations. Samples of each bacterial strain were thawed within an anaerobic chamber and serial 10-fold dilutions made using sterile dilution salts (12) . Duplicate 0.1-ml portions of each dilution were plated onto Brucella base blood agar and allowed to dry. Plates were incubated for 48 h at 370C within an anaerobic chamber and colonies enumerated. Before implantation, bacterial cultures were diluted to the appropriate concentration with sterile peptone yeast glucose broth (5) .
Challenge inocula. Three challenge inocula were prepared for implantation into rats. The first consisted of 1 X 108 colony-forming units (CFU)/ml of B. fragilis (ATCC23745). The second inoculum consisted of 5 X 107 CFU/ml of B. distasonis (ATCC8503) and 5 X 107 CFU/ml enterococcus (TVDL41). The third inoculum consisted of 5 X 107 CFU/ ml F. varium (TVDL3) and 5 X 107 CFU/ml enterococcus (TVDL41). All inocula contained 50% vol/vol cecal contents and 10% wt/vol barium sulfate as described previously (3) .
Control experiments have shown that neither barium sulfate nor cecal contents cause abscess formation by themselves, or in combination (3). Implantation of inoculum. Before implantation, animals were anesthetized with 0.15 ml (60 mg/ml) of nembutal and blood obtained by percutaneous cardiac puncture from appropriate groups for determination of antibody levels to B.
fragilis CP. Animals were shaved, prepped with betadine, and an anterior midline incision made through the skin and underlying musculature. A gelatin capsule containing 0.5 ml of inoculum was inserted through the incision and then closed with interrupted 3-0 silk sutures (3).
Evaluation of results. 7 d after implantation, animals were killed and necropsied in a "blind" fashion so that the prosecutor was not aware of which group of animals was being necropsied. Abscesses were considered to be present if loculated collections containing purulent exudates were found, which showed polymorphonuclear leukocytes and bacteria when examined microscopically. Cultures from randomly selected animals were obtained to insure the presence of only the challenge bacterial species. Statistical comparisons of the various groups containing abscesses were made using x2 analysis (13) , while a comparison of antibody levels was made using a t test for paired samples (14) .
T Cell-dependent Immunity to B. fragilis immunized animals appears to be specific for B. fra-cells from immunized animals suggested that protecgilis, since challenge of spleen cell recipient animals tion against B. fragilis-induced intraabdominal ab-
with F. varium plus enterococcus resulted in abscesses scesses was T cell-dependent. (Group J). Additionally, spleen cells transferred from
Efficacy of active immunization in athymic rats. nonimmunized animals to nonimmunized recipients Active immunization of both OLA/Rnu normal and (group K) did not afford any protection to challenge athymic animals resulted in increased levels of serum with B. fragilis indicating that prior immunization of antibody to B. fragilis CP (Table V, groups M and 0). the donor was a requirement for protection.
These sera were taken at the time of necropsy. Despite These results indicated that specific protection increased levels of antibody, only the OLA/Rnu noragainst B. fragilis-induced abscess could be conferred mal animals were protected from B. fragilis-induced by adoptive transfer of spleen cells from animals im-abscesses (P < 0.05) as compared with nonimmunized munized with CP of B. fragilis. Measurement of serum controls (groups L and N) or immunized OLA/Rnu antibody to the CP at the time of challenge in these athymic animals. The presence of higher antibody levrecipients showed no substantial increase in antibody els in the immunized athymic rats compared with the levels over pretransfer levels, indicating that serum nonimmunized athymic animals might be interpreted antibody was not likely to be a factor in the protection. to indicate that the response was primarily a result of Moreover, the ability to transfer protection with spleen polysaccharide immunization as opposed to bacterial Efficacy of transfer of T cell-enriched spleen cell populations. Previous experiments showed that protection occurred when spleen cells from immune animals were adoptively transferred to nonimmune recipients challenged with B. fragilis. To better define the cell populations involved, T cell-enriched populations were obtained from immune spleen cells by separation on nylon wool columns. This method generally gave a yield of 1.1 X 107 cells/ml (22%) with warm (37°C) elution. This is consistent with previously published data for cell yields using nylon wool columns (11) . Cold elution (4°C), which elutes B cells and macrophages adherent during warm elution, yielded 1.6 X 10 cells/ml. Transfer of these T cell-enriched and B cell and macrophage populations to nonimmune recipients (groups P-S, Table VI) indicate that significant protection against abscess development occurs when immune T cell-enriched populations are transferred. B cell-and macrophage-enriched populations from the same spleens failed to transfer immunity to nonimmune recipients challenged with B. fragilis. The 50% protective dose (PD50) for T cell enriched transfer recipients was 3.2 X 105 cells, while the PD50 for the B cell and macrophage recipients was >2 X 106 cells. (15) , any defects in the immune response have been shown to be due to the absence of T cells. Clearly, the absence of T cells in athymic rats results in a lack of protection against B. fragilis-induced abscesses, despite the presence of serum antibody. Proof of this fact was obtained by additional experiments in which T cell-enriched and B cell/macrophage populations obtained from the spleens of immunized animals were transferred to nonimmune recipients. These experiments revealed that T cell recipients were protected against B. fragilisinduced abscesses but B cell and macrophage recipients were not. These data indicate that immunity to B. fragilis-induced intraabdominal abscesses is T celldependent.
T cell-dependent immunity to bacterial antigens is not unique to B. fragilis. Immunity to both Mycobacterium tuberculosis (15, 16) and Listeria monocytogenes (17, 18) has been shown to be T cell-dependent, and interestingly, another abscess producing organism, Staphylococcus aureus, has also been shown to elicit delayed hypersensitivity in mice (19) . The effector mechanism by which T cell-dependent immunity against B. fragilis-induced abscesses operates has yet to be defined. Most human sera tested contain detectable antibody to B. fragilis (2) , yet virtually all patients exposed to fecal contamination develop intraabdominal abscesses when antibiotic therapy fails to include coverage against anaerobes (20) . The majority of such infections yield B. fragilis when cultured (21) . These data indicate that the presence of circulating antibody to the surface antigen may not serve as a useful predictive measure for B. fragilis-induced abscesses. An important supporting clinical observation suggesting the importance of T cell-dependent immunity is a recent report of the association of B. fragilis with postappendectomy infections in profoundly lymphocytopenic patients (22) .
A considerable body of evidence indicates that polysaccharides are able to elicit antibody response in research animals and man. B. fragilis CP is capable of functioning as a T-independent antigen in the classical manner of other polysaccharides as demonstrated by the ability of this antigen to stimulate antibody in athymic rats. There is much less evidence to support the concept that these antigens can stimulate a T celldependent response, although reports of induction of such responses do exist (23) (24) (25) . The antigen used for immunization in the current studies is a polysaccharide and contains no detectable protein. The secondary structure of this polysaccharide has not been determined.
From these studies it is apparent that both the cellular and humoral limbs of the immune system play important roles in protection against B. fragilis infection. As would be expected, antibody protects against bacteremia with these encapsulated bacteria. However, the distinctive pathological marker of B. fragilis infections is abscess formation and these studies indicate that T cell-dependent immunity protects against that process in this experimental model.
